HOME > SOCIETY > National Injury Control Program to save lives on Road : JP Nadda

National Injury Control Program to save lives on Road : JP Nadda

accident

The Health Ministry will soon come out with a National Injury Control Program to provide health care and save lives of the lakhs of persons lost in accidents and to injury, announced health minister J P Nadda, while inaugurating the Third World Trauma Congress today.

“Road traffic injuries are among the three leading causes of death for people between 5 and 44 years of age,” Nadda pointed out. “Unless immediate and effective action is taken, road traffic injuries are predicted to become the 5th leading cause of death in the world, resulting in an estimated 24 lakh deaths each year,” he stated.

As per the latest statistic, in India 52 persons die every hour in various accidents.

Road injuries and deaths cause a colossal economic cost of up to 1.5% of the Gross National Product.

Nadda also said that to meet the challenges of trauma patients, we need to advance not only clinical practice and medical technology, but also the organization of our health care system and resources. He also urged for more convergence with Ministries such as Road Transport and Highways and other related stakeholders.

India is hosting the 3rd World Trauma Congress this year, the first and second one’s being held at ‘Rio de Jenario’ and ‘Frankfurt’.

Follow ULTRA.news
NATCO Pharma to sell multiple sclerosis drug in USA via Mylan NATCO Pharma Limited said it the US Food and Drug Administration approved the generic drug application filed by its marketing partner Mylan for injections used in the treatment of multiple sclerosis, a chronic inflammatory disease of the central nervous system.The drug, Glat...
AU Small Finance Bank to distribute Aditya Birla Health insurance AU Small Finance Bank has tied up with Aditya Birla Health Insurance to to distribute the latter's health insurance products.The bank will act as a corporate agent, it said."This tie up shall be mutually beneficial for ABHICL & AU SMALL FINANCE BANK in terms of business,...
Piyush Goyal orders safety and capacity audit for Mumbai foot-overbridges Railway minister Piyush Goyal said he has ordered a 'safety and capacity' audit of all foot-overbridges in Mumbai.The order comes in the wake of the death of around 25 people in a stampede on a narrow foot-overbridge in the Elphinstone station.He also said that the Railwa...
Glenmark Pharma gets USFDA approval for Desonide skin ointment Pharma giant Glenmark Pharmaceuticals said it received final approval to sell skin oinment Desonide Lotion in the US.The ointment has annual sales of approximately $23.2 million.The medicine is used to treat eczema, dermatitis, allergies, rashes etc.Desonide reduces...
Glenmark to launch Desonide topical ointment in US Glenmark Pharmaceuticals Inc said it has got the go-ahead to launch the generic version of Perrigo's anti-inflammation ointment Desonide Ointment in the US.Desonide Ointment, 0.05% had annual sales of approximately $23.4 million for the 12 month period ending July 2017, acco...
Solar Power is a life saver in Chhattisgarh – Survey The solar energy revolution may be all about saving the environment, but for the Indian state of Chhattisgarh, it's impact is more immediate, and life-saving.According to a first-of-its-kind study conducted on primary health centers in the state, PHCs with solar backup admit...
10.6% of Indians have mental disorders; country faces severe shortage About 10.6% of adults in India suffer from some sort of mental disorder, including substance abuse problems, a study by the National Institute of Mental Health and Neurosciences or NIMHANS found.The study was conducted in 12 states of India by the Bangalore-based institution....
Measles makes a comeback, especially in North India The number of people getting infected with measles, a deadly disease that causes a red rash and is spread through the air, has shown a steady increase in four adjoining states of North India, as well as Gujarat.Measles is a highly contagious infection caused by the measles vi...
Zydus Cadila gets USFDA approval for generic version of popular migraine drug Zydus Cadila said it received final approval from the US Food and Drug Administration to market migraine drug Eletriptan Hydrobromide in the US.The drug is currently marketed and manufactured by Pfizer Inc and sold in the US and Canada under the brand name Relpax.The two...
Karnataka tops in speedbreaker-related deaths in India The number of people killed by speedbreakers more than doubled in Karnataka to 2,310 in 2015, while they halved in Uttar Pradesh.Uttar Pradesh, which had reported the highest number of such deaths in 2014 at 3,192, saw the figure fall to 1,652 in the subsequent year,  data ob...
Explosion at BPCL refinery in Kochi There has been an explosion at the oil refinery in Kochi, operated by Bharat Petroleum Corporation Ltd.The explosion happened at the electricity generation plant at the refinery. The power plant works on gas and was undergoing maintenance.The BPCL refinery is crucial to t...
Bliss GVS Healthcare wins three-year contract worth Rs 760 cr from Kenya Bliss GVS Healthcare Ltd said it won a three year contract worth $111.40 mln (Rs 760 cr) from Aon Kenya Insurance Brokers Ltd for provision of medical health care services in Kenya. Bliss GVS Pharma Ltd is a pharmaceutical company based in Mumbai, India.Bliss GVS...
Marksans Pharma gets USFDA approval for sale of anti-allergy drug Marksans Pharma Limited, an Indian pharmaceutical company, said it has received approval from the USFDA for the sale sale of its Loratadine Liquid Filled Capsules 10 mg in the US market.Loratadine is an antihistamine that reduces the effects of natural chemical histamine in t...
Aurobindo Pharma to launch HIV drug in Africa this year, gets tentative FDA nod Aurobindo Pharma Limited, a pharmaceutical manufacturing company based in Hyderabad, said it received a tentative approval for HIV drug Dolutegravir from US Food & Drug Administration.It is the first FDA approval of a generic version of Dolutegravir. Through a tie up w...
Glenmark Pharma discovers potential new anti-cancer drug Glenmark Pharmaceuticals said its overseas subsidiary has discovered a molecule that can potentially be used in targeting even difficult-to-treat lung cancer and colorectal cancer.The GBR 1372 molecule was discovered in the pharma company's Swiss laboratory and that the compa...
US FDA updates warning against widespread use of fluoroquinolones The US Food & Drug Administration issued a warning against casual usage of fluoroquinolone antibiotics, arguably the most widely used broad-spectrum antibiotic in India.USFDA advised that the side effects caused by the use of fluoroquinolone antibacterial drugs would outw...
Ayush ministry signs MOU with US Pharmacopeial to strengthen traditional medicine Ministry of Ayush, government of India signed a memorandum of understanding (MOU) with United States Pharmacopeial Convention for cooperation in the field of traditional medicine.The aim is to promote the safety, quality and integrity of traditional medicines and botanical di...
Lupin gets approval for new indigestion tablets in India Lupin Ltd announced today that it has received approval to launch Acotiamide 100 mg indigestion tablets in India from the Central Drugs Standard Control Organization.Acotiamide is a drug to be introduced into the Indian Pharmaceutical Market which could benefit millions of p...
Govt to speed up correction accident spot on national highways National Highways Authority of India (NHAI) will be delegated power to approve plans for rectifying road design in black spots in an effort to reduce accidents on national highways, minister of Road Transport & Highways and Shipping Nithin Gadkari said.Nithin Gadkari addressi...
Glenmark announces discovery of novel cancer drug Glenmark Pharmaceuticals has announced the discovery of a new anti-cancer therapy by its Swiss subsidiary.The new drug, GBR 1302, will target breast cancer and ovarian cancer, and the company expects to start clinical studies this year.Unlike normal drugs, the new dru...